Pfizer Inc (PFE)

$26.87 +0.08 (0.30%)
Market Cap 152.69B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.79
Forward PE 9.00
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 19,591,529
Avg Vol 44,246,344
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 84%
Beta 0.34
Analysts Sell
Price Target $28.60

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
clan
clan Aug. 17 at 6:48 PM
$MNKD @neil36 @MrMulally @MayorofMNKD I wonder if the CEO of Mannkind could, or would, atleast hint at, or fully disclose, the names of the drug companies with which Mannkind has had recent discussions regarding collaborations putting their drug on Technosphere. Maybe, ... sounds-like-Lasagna🍝 just needs to be asked the question, in the right way, at the right time. #technosphere $PFE 🤔 $MRK 🤔 $AZN 🫵
1 · Reply
Silver3urfer_Trader
Silver3urfer_Trader Aug. 17 at 6:33 PM
$KHC $VICI opportunities here again. I made a nice $2K+ last week trading these. Keep a close eye on them. $SIRI paid a nice 2.00% nice. $PFE $VZ a little high, waiting for some resistance to see the play later on. Good luck out there in the world of stock investors/traders.
0 · Reply
jaqr
jaqr Aug. 17 at 6:20 PM
$PFE $3MM in inside purchase, who else is doing that?
0 · Reply
jaqr
jaqr Aug. 17 at 6:06 PM
$PFE So even the CEO bought $1MM last week? I had no idea about it, is there any rules where they must purchase X amount of days before any material announcement? i wonder if they are preparing to announce something with $3MM of insider purchase in less than 2 weeks
0 · Reply
Jack90
Jack90 Aug. 17 at 5:03 PM
$NKE $PFE $VZ I like dividend
1 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 17 at 5:01 PM
$PFE 27 is poison now… It’s an improvement
1 · Reply
reyofhope
reyofhope Aug. 17 at 4:51 PM
$PFE when do we moon?
1 · Reply
1hawk
1hawk Aug. 17 at 3:31 PM
$PFE got to assume this will go down after divy payment next month
3 · Reply
jackofalltrade
jackofalltrade Aug. 17 at 2:34 PM
$PFE With the huge increase in institutional ownership, Pfizer may not trade like it did in the past.
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 17 at 2:03 PM
$PFE looks like one of those days where we are absolutely not allowed to be green
1 · Reply
Latest News on PFE
Pfizer, Valneva announce EMA validation for PF-07307405 MAA

2026-08-16T13:55:21.000Z - 1 day ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

Pfizer (PFE) CEO Buys $1 Million of Company Stock

2026-08-14T18:45:04.000Z - 3 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 1:45 PM EDT - 3 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:46 AM EDT - 3 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Aug 14, 2026, 11:11 AM EDT - 3 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

2026-08-14T13:47:35.000Z - 3 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Aug 14, 2026, 1:00 AM EDT - 3 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-07T11:40:49.000Z - 10 days ago

Pfizer price target lowered to $31 from $35 at Guggenheim

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-06T13:09:00.000Z - 11 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

Pfizer price target raised to $27 from $26 at BofA

2026-08-05T10:45:23.000Z - 12 days ago

Pfizer price target raised to $27 from $26 at BofA

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 13 days ago

Pfizer Earnings Call Transcript: Q2 2026

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 13 days ago

Pfizer Earnings release: Q2 2026

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 13 days ago

Pfizer Slides: Q2 2026

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 13 days ago

Pfizer Quarterly report: Q2 2026

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 13 days ago

Pfizer Post Loss on Higher Revenue

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:13 AM EDT - 13 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Aug 4, 2026, 7:12 AM EDT - 13 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:52 AM EDT - 13 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 4, 2026, 6:45 AM EDT - 13 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

5 Things to Know Before the Stock Market Opens on Monday

Aug 3, 2026, 8:10 AM EDT - 14 days ago

5 Things to Know Before the Stock Market Opens on Monday

AMD AZN BMY CAT CVS DASH DIS

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 7:48 AM EDT - 18 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 30, 2026, 6:45 AM EDT - 18 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Jul 29, 2026, 4:30 PM EDT - 18 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:48 PM EDT - 25 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 22, 2026, 4:30 PM EDT - 25 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

Jul 21, 2026, 7:10 PM EDT - 26 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 16, 2026, 1:39 PM EDT - 4 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 10, 2026, 11:23 AM EDT - 5 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 6 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 6 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 29, 2026, 1:20 AM EDT - 7 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 7 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 2:10 PM EDT - 7 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 7 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 12:10 PM EDT - 7 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 23, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 7 weeks ago

Pfizer's experimental drug misses main goal of lung cancer trial

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 4:30 PM EDT - 7 weeks ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

clan
clan Aug. 17 at 6:48 PM
$MNKD @neil36 @MrMulally @MayorofMNKD I wonder if the CEO of Mannkind could, or would, atleast hint at, or fully disclose, the names of the drug companies with which Mannkind has had recent discussions regarding collaborations putting their drug on Technosphere. Maybe, ... sounds-like-Lasagna🍝 just needs to be asked the question, in the right way, at the right time. #technosphere $PFE 🤔 $MRK 🤔 $AZN 🫵
1 · Reply
Silver3urfer_Trader
Silver3urfer_Trader Aug. 17 at 6:33 PM
$KHC $VICI opportunities here again. I made a nice $2K+ last week trading these. Keep a close eye on them. $SIRI paid a nice 2.00% nice. $PFE $VZ a little high, waiting for some resistance to see the play later on. Good luck out there in the world of stock investors/traders.
0 · Reply
jaqr
jaqr Aug. 17 at 6:20 PM
$PFE $3MM in inside purchase, who else is doing that?
0 · Reply
jaqr
jaqr Aug. 17 at 6:06 PM
$PFE So even the CEO bought $1MM last week? I had no idea about it, is there any rules where they must purchase X amount of days before any material announcement? i wonder if they are preparing to announce something with $3MM of insider purchase in less than 2 weeks
0 · Reply
Jack90
Jack90 Aug. 17 at 5:03 PM
$NKE $PFE $VZ I like dividend
1 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 17 at 5:01 PM
$PFE 27 is poison now… It’s an improvement
1 · Reply
reyofhope
reyofhope Aug. 17 at 4:51 PM
$PFE when do we moon?
1 · Reply
1hawk
1hawk Aug. 17 at 3:31 PM
$PFE got to assume this will go down after divy payment next month
3 · Reply
jackofalltrade
jackofalltrade Aug. 17 at 2:34 PM
$PFE With the huge increase in institutional ownership, Pfizer may not trade like it did in the past.
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 17 at 2:03 PM
$PFE looks like one of those days where we are absolutely not allowed to be green
1 · Reply
Brice149
Brice149 Aug. 17 at 2:00 PM
$PFE Test 26.3 to 26.5 one more time then off to 28.5 please......
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 17 at 1:31 PM
$PFE yay we suck again
0 · Reply
nimii
nimii Aug. 17 at 1:29 PM
$PFE 😤
0 · Reply
La_Parka3
La_Parka3 Aug. 17 at 12:48 PM
$MRNA $PFE $BNTX $MRK The 2021 vaccine mandate is like a troubling ex-girlfriend to the antivaxxers: the beautiful lady left them a long time ago, but the heartache remains. Meanwhile, they’re mad at the other boys who still love her. 🙁
0 · Reply
BioGypsy
BioGypsy Aug. 17 at 12:29 PM
$CRDF $CRDF anyone think it’s pure coincidence that August 21st status conference, the lack of a pi decision and August 21 options expiring!!!! Kinda feels like a Nancy Peloci scam $PFE $AMGN
3 · Reply
JuggernautRaider
JuggernautRaider Aug. 17 at 10:52 AM
$ALT $BMY $PFE $TNXP Speaking of which… this launch is FLAT. WTF CEO Seth? John F Kennedy and Bill Clinton and LBJ were shit to women. I wish I never had to hear about those sexual assailants too. Senator Cory Booker (NJ) bragged about assaulting a woman while at Stanford in 1992. 😡 And I am SICK of poor leadership! I AM A BULL FULL OF RAGE IN A GLASS AMERICAN CAGE… of ICE 🧊 💪 🇺🇸
0 · Reply
JuggernautRaider
JuggernautRaider Aug. 17 at 10:49 AM
Why? All Americans are immigrants or migrants if you believe Humanity started in Africa. $TNXP 💊 @DeepBlueCyan … all I feel is pain 🤕 both my parents have fibromyalgia (muscle cramps & pain). I got it now too. It sucks! The Founding Fathers were Deists sir… like me. Thomas Jefferson was perhaps the biggest alcoholic in American Presidential history but also the smartest. He needed some pemvituvide $ALT 🍷 And how about $BMY ? The rock of South Jersey Pharmaceuticals? 🧬 Don’t forget Big Blue $PFE over the bridge. Big blue Bourla needs to retire too 👴
0 · Reply
DG20
DG20 Aug. 17 at 4:29 AM
$NVO $PFE $VKTX GLP + Amylin increases ☝️side effects. GLP + GIP decreases👇 side effects. Sema 7.2 + Cagrilinitide will produce a worse side effect profile than Cagrisema AND Bourla projects excitement, facts be damned… Facts 👇👇👇👇👇
0 · Reply
biolover
biolover Aug. 17 at 3:33 AM
$VKTX $PFE Bourla just in June at GS was talking about “ very high level of weight reduction” and Chris in Aug is saying don’t look at efficacy, this is just to define the dose for 900 pts study .. Which one to believe 😂? And $NVO is running sema 7.2 mg combo with cagrilintide 😂 $LLY is facing fierce competition and “ crowded sector “ 😂
0 · Reply
truthseeeker
truthseeeker Aug. 16 at 7:16 PM
$PFE to the poster predicting $30 by year end. < a dose of PFE reality is in order. Realistic knowledgeable PFE holders/investors/traders will be plenty happy if PFE holds $26 and does not do a patented PFE drawdown to below 25.
3 · Reply
AskLou
AskLou Aug. 16 at 6:52 PM
$ZTS what happened here? I never understood the premium valuation when it was spun from $PFE but what happened? Earning growth is flat but cash flow is excellent. Has private equity sucked all the discretionary cash out of the vet industry?
1 · Reply
Antipig
Antipig Aug. 16 at 3:03 PM
$MRNA $PFE https://www.zerohedge.com/covid-19/fauci-hiding-abc-censorship-bombshell-explodes?utm_source=daily_newsletter&utm_medium=email&utm_campaign=8938
0 · Reply